selected scholarly activity
-
chapters
- The Stomach. 31-65. 2022
- Duodenal Ulcer. 90-102. 2020
- Actors, Patients and Agency: A Recent History. 7-18. 2014
- Epidemiology of GERD, Barrett's Esophagus and Esophageal Cancer. 119-134. 2014
- Epidemiology of GERD, Barrett's esophagus and esophageal cancer. 121-134. 2014
- Bariatric Surgery and Its Effects on Heart Rate Variability. 279-299. 2013
- Bariatric Surgery and Its Effects on Heart Rate Variability. 279-300. 2012
- Evaluation as an Innovative Health Technology. 232-241. 2006
-
conferences
- SIMILAR RATE OF POST-COVID-19 SYMPTOMS IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF AN INTERNATIONAL CROSS-SECTIONAL STUDY. Gastroenterology. S1033-S1034. 2023
- THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSSSECTIONAL STUDY. Gastroenterology. S1034-S1034. 2023
- Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial. American Journal of Gastroenterology. S272-S273. 2022
- 59 A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (Born): The Born Project. Gastrointestinal Endoscopy. AB48-AB48. 2017
- ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS. Gastroenterology. S45-S45. 2017
- Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia. Gastroenterology. S939-S939. 2017
- EFFECT OF DIET ON GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) STRATIFIED BY ANTIGLIADIN (AGA) ANTIBODIES. Annals of Nutrition and Metabolism. 1018-1018. 2017
- ROLE OF EMPIRIC ANTI-REFLUX THERAPY IN PEDIATRIC OTITIS MEDIA WITH EFFUSION - A PILOT STUDY. European Journal of Pediatrics. 1658-1658. 2016
- Post Analysis of Polyps in 9 Short Bowel Syndrome Patients Treated with Teduglutide. American Journal of Gastroenterology. S241-S241. 2016
- Tu1138 The BORN Project: A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (BORN). Gastrointestinal Endoscopy. AB550-AB550. 2016
- Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies. Gastroenterology. S743-S744. 2016
- Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study. Gastroenterology. S235-S235. 2016
- Su1897 Inflammation-Related Differences in Mucosa-Associated Microbiota and Paracellular Permeability in Crohn's Colitis. Gastroenterology. S582-S582. 2016
- Anxiety and depression may lead to poor health-related quality of life in patients with inflammatory bowel disease. Journal of Crohn's and Colitis. S154-S154. 2016
- Living with inflammatory bowel disease: results from focus group. Journal of Crohn's and Colitis. S499-S500. 2016
- P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD). Inflammatory Bowel Diseases. S34-S34. 2016
- P-231 YI Patient Experience Living with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. S79-S79. 2016
- Telephone vs clinic follow-up in the management of patients with inflammatory bowel disease: a nurse practitioner-led study. Journal of Crohn's and Colitis. S495-S495. 2016
- A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective. American Journal of Gastroenterology. S758-S758. 2015
- Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology. American Journal of Gastroenterology. S754-S755. 2015
- Mucosal Features of Colonic Crohn’s Disease Determined by Confocal Laser Endomicroscopy (CLE): An Inter-observer Agreement Study. American Journal of Gastroenterology. S507-S507. 2014
- A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.. Gastroenterology. S159-S159. 2014
- Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease. Gastroenterology. S583-S583. 2014
- Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. Gastroenterology. S470-S471. 2014
- Integrating Data from EHRs to Enhance Clinical Decision Making: The Inflammatory Bowel Disease Case. Proceedings of the IEEE Symposium on Computer-Based Medical Systems. 531-+. 2014
- Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. Gastroenterology. S902-S902. 2014
- P309 Transition experience from inpatient to ambulatory IBD care: Results of a pilot study. Journal of Crohn's and Colitis. S193-S194. 2014
- Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic. Gastroenterology. S651-S651. 2013
- Does Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease Impact Clinical Management? A Canadian Experience.. Inflammatory Bowel Diseases. S82-S83. 2012
- Current Management Practices for Moderate-To-Severe Gastroesophageal Reflux Disease (GERD) in Canadian Primary Care Practice. American Journal of Gastroenterology. S594-S595. 2012
- Point Prevalence of Malnutrition Risk in a Tertiary Care Academic Hospital. American Journal of Gastroenterology. S137-S138. 2012
- Communicating Gastrointestinal (GI) Symptoms: the Patient's Challenge. Gastroenterology. S579-S579. 2012
- Why doesn't Crohn's Disease DNA-based risk information motivate quitting? A qualitative study. Psychology and Health. 141-141. 2012
- Interdisciplinary, prompt access IBD clinic: The hamilton health science experience. Inflammatory Bowel Diseases. S7-S7. 2011
- Barrett's Dysplasia Cancer Task Force - Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus. Gastroenterology. S178-S178. 2011
- Integrated CMOS sensors for fluorescence spectroscopy and imaging. 2009 Asia Communications and Photonics Conference and Exhibition, ACP 2009. 2009
- Epidemiology of Blood Stream Infections in a Hospital-Based, Home Parenteral Nutrition Program. American Journal of Gastroenterology. S108-S108. 2009
- Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A439-A440. 2009
- Information Needs of Digestive Disease Patients: the Patient Education Needs Survey (PENS). Gastroenterology. A638-A638. 2009
- Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A435-A435. 2009
- The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial. Gastroenterology. A439-A439. 2009
- Integrated CMOS Sensors for Fluorescence Spectroscopy and Imaging. Optics InfoBase Conference Papers. 2009
- Integrated CMOS sensors for fluorescence spectroscopy and imaging. Optics InfoBase Conference Papers. 1-2. 2009
- Predictors of bowel preparation quality in patients undergoing colonoscopy - a preliminary analysis. Gastroenterology. A319-A319. 2008
- Immunohistochemical demonstration of esophageal dilated intercellular spaces (DIS) in squamous mucosa. Modern Pathology. 133A-134A. 2008
- Immunohistochemical demonstration of esophageal dilated intercellular spaces (DIS) in squamous mucosa. Laboratory Investigation. 133A-134A. 2008
- Symptom Assessment. Journal of Clinical Gastroenterology. S184-S192. 2007
- Endoscopic Ultrasound: A Meta-Analysis of Test Performance in Suspected Choledocholithiasis. Gastrointestinal Endoscopy. AB360-AB360. 2007
- Endoscopy Training for GI Trainees: The Impact of a 2-Day Introductory Training Course On Cognitive Knowledge. Gastrointestinal Endoscopy. AB312-AB312. 2007
- GI Endoscopy Training: Validation of a Computer-Based Endoscopy Simulator. Gastrointestinal Endoscopy. AB316-AB316. 2007
- Inhibition of acid secretion by a novel proton pump inhibitor (PPI). Gastroenterology. A486-A486. 2007
- S-tenatoprazole-na 30 Mg, 60 Mg and 90 Mg versus esomeprazole (Eso) 40 Mg in healthy male volunteers (Hmvs). Gastroenterology. A488-A489. 2007
- Baseline analysis of symptom spectrum in GORD: results from ReQuest (TM) database. Journal of Gastroenterology and Hepatology. A248-A248. 2006
- International GORD symptom thresholds based on the ReQuest (TM) questionnaire definition of symptom relief in clinical studies. Journal of Gastroenterology and Hepatology. A356-A356. 2006
- AGN 201904-Z (AGN), a Novel Enteric-Coated PPI, Produces Greater, More Prolonged Acid Suppression Than Esomeprazole (ESO) in Healthy Male Volunteers. American Journal of Gastroenterology. S92-S92. 2006
- Oral Rabeprazole 20 Mg Provides More Effective Acid Control Than IV Pantoprazole 40 Mg. American Journal of Gastroenterology. S80-S80. 2006
- Targeted esophageal biopsies: What you see is what you get (WYSIWYG) - Or not?. Gastroenterology. A161-A162. 2006
- Esomeprazole and pantoprazole: A comparison for maintenance treatment of healed erosive oesophagitis. Gut. A14-A14. 2005
- Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004. Canadian Journal of Gastroenterology and Hepatology. 15-35. 2005
- Management of adenocarcinoma risk: Discussion. Alimentary Pharmacology and Therapeutics, Supplement. 95-96. 2004
- PGI9 RESPONSIVENESS TO CHANGE AND ENGLISH LANGUAGE VALIDATION OF THE WPAI-GERD QUESTIONNAIRE-RESULTS FROM A CANADIAN STUDY. Value in Health. 349-349. 2004
- PGS6: THE COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH UNINVESTIGATED DYSPEPSIA (UD): COMPARING THE CANDYS APPROACH TO EMPIRICAL ANTISECRETORY THERAPY AND PROMPT ENDOSCOPY. Value in Health. 246-247. 2003
- Magnet-tracing (MT) in the gastrointestinal (GI) tract: a new technique for non-invasive verification of nasogastric tube (NGT) placement. Gastroenterology. A24-A25. 2003
- Orocecal transit times (OCTT) in healthy subjects assessed by magnet-tracing (MT) and lactulose breath hydrogen test (LBHT). Gastroenterology. A426-A426. 2003
- The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care. Gastroenterology. A223-A224. 2003
- The prevalence of Barrett's esophagus in primary care patients with uninvestigated dyspepsia. Gastroenterology. A644-A644. 2003
- High dose intravenous proton pump inhibitors (IV PPI) decrease hospital mortality in selected patients with upper gastrointestinal bleeding. American Journal of Gastroenterology. S230-S230. 2002
- Predictors of treatment response and relapse for heartburn-dominant uninvestigated dyspepsia (HBDUD) in primary care practice (PCP): the CADET-HR study. American Journal of Gastroenterology. S36-S36. 2002
- Predictors of treatment response in patients with endoscopy-negative reflux disease (ENRD). American Journal of Gastroenterology. S12-S12. 2002
- Home-care parenteral nutrition (PN) is cost-saving: Economic analysis of a home PN (HPN) service in Ontario, Canada.. American Journal of Clinical Nutrition. 429S-429S. 2002
- Desirable impacts on acid reflux and gastric pH. European Journal of Gastroenterology and Hepatology. S50-S53. 2001
- Diagnostic significance, provocants and time-course of heartburn and regurgitation. European Journal of Gastroenterology and Hepatology. S21-S22. 2001
- Should acid reflux be abolished in patients with oesophageal columnar metaplasia?. European Journal of Gastroenterology and Hepatology. S38-S40. 2001
- Symptom status as a surrogate for absence of endoscopic oesophagitis. European Journal of Gastroenterology and Hepatology. S76-S78. 2001
- The role of Helicobacter pylori (H.p.) infection in predicting endoscopic abnormalities in 1040 patients with uninvestigated dyspepsia (UD). The CADET-PE study. Gut. A96-A96. 2001
- Gastroesophageal reflux disease (GERD) symptoms (GS) in 5 European countries: a common and poorly understood condition. Gastroenterology. A427-A427. 2001
- Intravenous acid suppression - Appropriateness of use in a tertiary care setting. Gastroenterology. A730-A730. 2001
- Is prompt endoscopy necessary in uninvestigated dyspeptics? Prevalence of upper gastrointestinal abnormalities - The CADET-PE study.. Gastroenterology. A50-A51. 2001
- Significant and rapid HRQoL improvement correlates with symptom relief in GERD patients using pantoprazole (Panto) as compared to nizatidine (Niza).. Gastroenterology. A433-A433. 2001
- Session 4: Long-term medical management. European Journal of Gastroenterology and Hepatology. 2001
- Association of family history of gastric cancer, intestinal metaplasia and high gastric juice ammonia in patients with Helicobacter pylori infection. Gastroenterology. A1216-A1216. 2000
- Can symptoms be used to diagnose lactose intolerance?. Gastroenterology. A373-A373. 2000
- Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative gerd: A placebo-controlled trial of on-demand therapy for 6 months. Gastroenterology. A658-A658. 2000
- The test and treat strategy for dyspepsia: Cost-effectiveness of the order of eradication strategies. Gastroenterology. A207-A207. 2000
- “Step-up” or step-down? A 4-week comparison of pantoprazole, 40 mg daily and nizatidine, 150 mg bid in symptomatic gastroesophageal reflux disease (GERD). Gastroenterology. A1212-A1212. 2000
- C-13-urea breath test or H-pylori serology for the initial evaluation of young patients with ulcer-like dyspepsia: A decision analysis. Gastroenterology. A78-A78. 1999
- Cost-effectiveness of acid suppression versus misoprostol in the prevention of non-steroidal antliinflammatory drug (NSAID)-induced ulcers. Gastroenterology. A72-A72. 1999
- Gastroesophageal reflux disease (GERD): Is the "acid test" sufficient?. Gastroenterology. A114-A114. 1999
- Two-lumen tubing is required for accurate barostat studies. Gastroenterology. A846-A846. 1998
- A novel approach to assess brain processing of esophageal sensation using cognitive evoked P300-potentials. Gut. A82-A82. 1997
- Apparent increase in acid output during omeprazole (OME) after cure of H-pylori infection (HpI).. Gastroenterology. A70-A70. 1997
- Barostat-controlled, rectal distention modifies heart rate variability in healthy subjects.. Gastroenterology. A693-A693. 1997
- A low resting vagal tone predicts response to acid perfusion in patients with esophageal symptoms.. Gastroenterology. A762-A762. 1996
- Autonomic response to esophageal acid perfusion in patients with esophageal symptoms.. Gastroenterology. A762-A762. 1996
- Barostat-controlled esophageal balloon distension produces a pressure-dependent heart rate decrease in healthy subjects. Gastroenterology. A624-A624. 1996
- Differences in acid secretory response and serology in H-pylori positive patients after successful and failed triple therapy. Gastroenterology. A142-A142. 1996
- H-pylori related increase in omeprazole (OME) effect is associated with ammonia production.. Gastroenterology. A64-A64. 1996
- Intragastric pH and omeprazole (OME): Role of Helicobacter pylori (HP) and HP-associated gastritis.. Gastroenterology. A285-A285. 1996
- Low pressure, unperceived, barostat-controlled esophageal distension decreases heart rate in healthy subjects. Gastroenterology. A625-A625. 1996
- Production of volatile amines by Helicobacter pylori (HP) is not relevant in vivo.. Gastroenterology. A285-A285. 1996
- A PREDICTIVE MODEL OF MUCOSAL DAMAGE IN GERD USING AREA-UNDER-THE-CURVE ESTIMATION OF HYDROGEN-ION ACTIVITY (AUC H+). Gastroenterology. A55-A55. 1995
- Effect of curing Helicobacter pylori (HP) infection on intragastric pH during omeprazole treatment. Gastroenterology. A250-A250. 1995
- PROTRACTED GASTRIC-ACID SECRETION IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION. Gastroenterology. A122-A122. 1995
- When should the position of Z-line and hiatus be measured during upper gastrointestinal endoscopy (UGE)?. Gastroenterology. A84-A84. 1995
- Methods to study gastric emptying. Digestive Diseases and Sciences. 130S-132S. 1994
- LANSOPRAZOLE AND OMEPRAZOLE, AT THERAPEUTIC DOSES, PRODUCE EQUIVALENT RISES IN GASTRIC PH IN HELICOBACTER-PYLORI (HP) POSITIVE SUBJECTS. Gastroenterology. A205-A205. 1994
- DOES THE TREATMENT AND HEALING OF ESOPHAGITIS INFLUENCE THE PATHOPHYSIOLOGY OF REFLUX DISEASE. International Congress Series. 470-480. 1994
- THE MUSE SYSTEM. International Congress Series. 313-318. 1994
- An amperometric enzyme electrode for bile acids. Analytica Chimica Acta. 655-661. 1993
- A COMPARISON OF 2 METHODS FOR THE ENDOSCOPIC ASSESSMENT OF REFLUX ESOPHAGITIS (RO). Gastroenterology. A35-A35. 1993
- DOES RAPID HEALING OF PEPTIC-ULCER PREDISPOSE TO EARLIER RELAPSE. Gastroenterology. A35-A35. 1993
- DUODENOGASTRIC REFLUX (DGR) MONITORING - IS GASTRIC PH-METRY ADEQUATE. Gastroenterology. A218-A218. 1993
- INFLUENCE OF PERSONALITY-CHARACTERISTICS (PC) AND STRESS (S) ON DUODENAL-ULCER (DU) RECURRENCE (R). Gastroenterology. A73-A73. 1993
- LUMINAL DISTENSION, MOTILITY PATTERNS AND LUMINAL TRANSPORT IN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- MECHANICAL CORRELATES OF INTESTINAL FLUID-FLOW IN AN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- Multichannel ISFET catheter for temporal and spatial pH variation studies in the stomach over 24 hours. Sensors and Actuators, B: Chemical. 332-335. 1992
- Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical?. Hepato-Gastroenterology: current medical and surgical trends. 3-13. 1992
- THE ROLE OF THE ENS IN SMALL INTESTINAL MOTILITY - STUDIES IN AN ISOLATED ARTERIALLY-PERFUSED LOOP INVITRO. European Journal of Neuroscience. 147-147. 1992
- DUODENAL ULCERATION DURING MAINTENANCE RANITIDINE THERAPY - SILENT AND DEADLY. Gut. A584-A584. 1991
- MISOPROSTOL DOES NOT PREVENT THE GASTRODUODENAL MUCOSAL EFFECTS OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUG, DICLOFENAC. Gut. A571-A571. 1991
- PERSISTENT GASTRITIS AFTER RANITIDINE OR ANTACID THERAPY PREDICTS RELAPSE OF DUODENAL ULCERATION. Gut. A595-A595. 1991
- Circadian rhythms of gastric acidity in healthy man. Hepato-Gastroenterology: current medical and surgical trends. 262-263. 1990
- 24 HOUR PATTERN OF ESOPHAGEAL MOTILITY. Gut. A1491-A1491. 1989
- COMPUTER ANALYZED AMBULATORY MANOMETRY OF ESOPHAGEAL MOTILITY. Gut. A1491-A1492. 1989
- FULL DOSE H2 RECEPTOR ANTAGONIST PROPHYLAXIS DOES NOT PREVENT RELAPSE OF REFLUX ESOPHAGITIS. Gut. A1494-A1494. 1989
- CHRONIC ENTEROGASTRIC REFLUX (EGR) INCREASES THE GASTROTOXICITY OF AN ACUTE BILE-ACID CHALLENGE IN THE RAT. Gut. A1477-A1478. 1988
- THE RELATIVE GASTROTOXICITY OF DUODENAL JUICE COMPONENTS - ACUTE STUDIES IN THE RAT. Gastroenterology. A13-A13. 1988
- IS CONTINUOUS AMBULATORY MONITORING OF DUODENOGASTRIC REFLUX FEASIBLE - INVITRO ASSESSMENT OF AN ENZYMATIC AMPEROMETRIC BILE-ACID ELECTRODE. Gut. A1395-A1395. 1987
- THE DIFFERING GASTROTOXICITY OF VARIOUS BILE-ACIDS - STUDIES WITH AN EXVIVO RAT GASTRIC CHAMBER MODEL. Clinical Science. P45-P45. 1987
- ARE BILE-ACIDS GASTROTOXIC IN DUODENOGASTRIC REFLUX - DOSE-RESPONSE AND STRUCTURE ACTIVITY STUDIES USING AN EXVIVO RAT GASTRIC CHAMBER MODEL. Gut. 1235-1235. 1986
-
journal articles
- Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?. Journal of the Canadian Association of Gastroenterology. 7:312-318. 2024
- Risk of fibromyalgia following antibiotic prescriptions: A population‐based case–control study. European Journal of Pain. 28:1008-1017. 2024
- Enteral nutrition on discharge from intensive care and 30-day unplanned readmission: An exploratory, retrospective study of association. Clinical Nutrition ESPEN. 61:15-21. 2024
- The Canadian Association of Gastroenterology’s New Climate Change Committee. Journal of the Canadian Association of Gastroenterology. 7:135-136. 2024
- Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review. BMJ Open. 14:e079750-e079750. 2024
- Nutrition Assessment and Management in Celiac Disease. Gastroenterology. 167:116-131.e1. 2024
- Symptom Profile, Proton Pump Inhibitor Therapy, and Diagnostic Testing in Patients With Persistent Reflux-Like Symptoms: Results From a Population-Based Survey. Foregut: The Journal of the American Foregut Society. 4:32-39. 2024
- Comment on Chao, H.-C. Zinc Deficiency and Therapeutic Value of Zinc Supplementation in Pediatric Gastrointestinal Diseases. Nutrients 2023, 15, 4093. Nutrients. 16:134-134. 2023
-
Editorial: On‐demand vonoprazan for
NERD – when should it be ‘demanded’? Authors' reply. Alimentary Pharmacology and Therapeutics. 58:1231-1231. 2023 -
Randomised clinical trial: Efficacy and safety of
on‐demand vonoprazan versus placebo for non‐erosive reflux disease. Alimentary Pharmacology and Therapeutics. 58:1016-1027. 2023 - Ethnic differences in physical and mental multimorbidity in working age adults with a history of depression and/or anxiety. Psychological Medicine. 53:6212-6222. 2023
- Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 47:878-887. 2023
- The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial. Pilot and Feasibility Studies. 9:124. 2023
- Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease.. Gastroenterology and Hepatology. 19:295-298. 2023
- The social life of risk probabilities in medicine. Social Science and Medicine. 323:115811-115811. 2023
- Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity. Nutrients. 15:1475-1475. 2023
- NutriSup-PPN: A pilot randomized control trial of oral nutritional supplementation (ONS) and peripheral parenteral nutrition (PPN) in canadian, malnourished, hospitalized patients. Clinical Nutrition ESPEN. 53:107-112. 2023
- The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development. Journal of Clinical Epidemiology. 154:197-203. 2023
- Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients. Gastroenterology. 164:228-240. 2023
- Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia. Middle East Journal of Digestive Diseases. 15:5-11. 2023
- Physical multimorbidity, depressive symptoms, and social participation in adults over 50 years of age: findings from the English Longitudinal Study of Ageing. Aging & Mental Health. 27:43-53. 2023
- Micronutrient deficiencies are frequent in adult patients with and without celiac disease on a gluten-free diet, regardless of duration and adherence to the diet. Nutrition. 103-104:111809-111809. 2022
- Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis. Middle East Journal of Digestive Diseases. 14:382-395. 2022
- Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey. Neurogastroenterology and Motility. 34:e14387. 2022
- Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 56:794-797. 2022
- Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients. Inflammatory Bowel Diseases. 28:e120-e120. 2022
- Rise and fall of the (social) group. Social Studies of Science. 52:618-634. 2022
- Psychometric origins of depression. History of the Human Sciences. 35:127-143. 2022
- Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett’s Esophagus: World Endoscopy Organization Delphi Study. Gastroenterology. 163:84-96.e2. 2022
- Diarrhea during critical illness: a multicenter cohort study. Intensive Care Medicine. 48:570-579. 2022
- Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist. ACP journal club. 175:735-739. 2022
- Prospective associations between depression and risk of hospitalisation for infection: Findings from the UK Biobank. Brain, Behavior, and Immunity. 102:292-298. 2022
- Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021. Current Oncology. 29:1723-1743. 2022
- Home parenteral nutrition in older vs younger patients: Clinical characteristics and outcomes. Journal of Parenteral and Enteral Nutrition. 46:348-356. 2022
- Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 5:12-17. 2022
- The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions. Nutrition Reviews. 80:215-229. 2022
- A Real-Time Endoscope Motion Tracker. IEEE Journal of Translational Engineering in Health and Medicine. 10:1-9. 2022
- Prior antibiotics and risk of subsequent Herpes zoster: A population-based case control study. PLoS ONE. 17:e0276807-e0276807. 2022
- Are some feasibility studies more feasible than others? A review of the outcomes of feasibility studies on the ISRCTN registry. Pilot and Feasibility Studies. 7:195. 2021
- Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes. BMC Health Services Research. 21:172. 2021
- Depressive symptoms during early adulthood and the development of physical multimorbidity in the UK: an observational cohort study. The Lancet Healthy Longevity. 2:e801-e810. 2021
- Guideline-based quality assurance: a conceptual framework for the definition of key elements. BMC Health Services Research. 21:173. 2021
- Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study. European Journal of Gastroenterology and Hepatology. 33:e634-e641. 2021
- Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clinical Gastroenterology and Hepatology. 19:2343-2352.e8. 2021
- Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste. Gastroenterology. 161:1354-1360. 2021
- Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Nonrecyclable Waste. Journal of Clinical Gastroenterology. 55:823-829. 2021
- Uniting the global gastroenterology community to meet the challenge of climate change and non-recyclable waste. Gut. 70:2025-2029. 2021
- Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. Journal of the Canadian Association of Gastroenterology. 4:214-221. 2021
- Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank. The Lancet Regional Health - Europe. 8:100149-100149. 2021
- The COVID‐19 pandemic and cause of death. Sociology of Health and Illness. 43:1614-1626. 2021
- Convolutional neural networks for medical image analysis: State-of-the-art, comparisons, improvement and perspectives. Neurocomputing. 444:92-110. 2021
- Home parenteral nutrition patients on mixed oil lipid emulsion have a higher rate of hospitalizations compare to those on soybean oil– a prospective 2-year cohort study. Clinical Nutrition. 40:4616-4623. 2021
- Survival of Patients With Short‐Bowel Syndrome on Home Parenteral Nutrition: A Prospective Cohort Study. Journal of Parenteral and Enteral Nutrition. 45:1083-1088. 2021
- Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflammatory Bowel Diseases. 27:836-847. 2021
- Comment on: Influence of prior antibiotic use on risk of rheumatoid arthritis: case–control study in general practice. Reply. Rheumatology. 60:e150-e150. 2021
- Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes. 13:1-18. 2021
- Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach. Clinical and Experimental Gastroenterology. Volume 14:123-131. 2021
- WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. Journal of Clinical Gastroenterology. 55:1-11. 2021
- Approaches of integrating the development of guidelines and quality indicators: a systematic review. BMC Health Services Research. 20:875. 2020
- Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respiratory Research. 21:3. 2020
- Personal Protective Equipment for Endoscopy in Low-Resource Settings During the COVID-19 Pandemic. Journal of Clinical Gastroenterology. 54:833-840. 2020
- Lean implementation within healthcare: imaging as fertile ground. Journal of Health Organization and Management. 34:869-884. 2020
- An Electronic Clinical Decision-Making Tool for Patients with Suspected Colorectal Cancer—Preliminary Evaluation in Patients Presenting with Rectal Bleeding. Journal of the Canadian Association of Gastroenterology. 3:204-209. 2020
- Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 55:800-805. 2020
- Association Between Age and Complications After Outpatient Colonoscopy. JAMA network open. 3:e208958-e208958. 2020
- Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series. Clinical Nutrition. 39:1774-1777. 2020
- Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. Rheumatology. 59:1281-1287. 2020
- Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:98-99. 2020
- The association between colorectal cancer and prior antibiotic prescriptions: case control study. British Journal of Cancer. 122:912-917. 2020
- Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:e1-e9. 2020
- Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD. Frontiers in Pediatrics. 8:620189. 2020
- Optical Biopsy of the Upper GI Tract Using Fluorescence Lifetime and Spectra. Frontiers in Physiology. 11:339. 2020
- Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom. PLoS ONE. 15:e0230674-e0230674. 2020
- Anxiety, Depression and Quality of Life Improve After One Month and Three Months of Home Parenteral Nutrition: A Pilot Study in a Canadian Population. Journal of the Canadian Association of Gastroenterology. 2:178-185. 2019
- Ethnic differences in psychosis—Lay epidemiology explanations. Health Expectations. 22:965-973. 2019
- Obesity and Weight Change in Two United Kingdom Male Prisons. Journal of Correctional Health Care. 25:328-337. 2019
- Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. Health Technology Assessment. 23:1-88. 2019
- Prisons and Embodiment: Self-Management Strategies of an Incarcerated Population. Journal of Correctional Health Care. 25:338-350. 2019
- Diagnosis: From classification to prediction. Social Science and Medicine. 237:112444-112444. 2019
- Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. Arab Journal of Gastroenterology. 20:175-179. 2019
- Variations in practice patterns for adult cancer patients on home parenteral nutrition in Canada. Nutrition. 65:27-32. 2019
- Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations. Plastic and Reconstructive Surgery - Global Open. 7:e2371-e2371. 2019
- Proton pump inhibitors and gastric cancer: association is not causation. Gut. 68:1529.2-1530. 2019
- Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 2:132-140. 2019
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 58:S1-S109.e33. 2019
- Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. 17:1477-1488.e10. 2019
- Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study. BMJ Open. 9:e028237-e028237. 2019
- Multi‐centre ethics and research governance review can impede non‐interventional clinical research. Internal Medicine Journal. 49:722-728. 2019
- Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation. Annals of the Rheumatic Diseases. 78:688-695. 2019
- An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett’s Esophagus–Related Neoplasia. Gastroenterology. 156:1299-1308.e3. 2019
- The social life of data points: Antecedents of digital technologies. Social Studies of Science. 49:102-117. 2019
- Associations Between Colonic Motor Patterns and Autonomic Nervous System Activity Assessed by High-Resolution Manometry and Concurrent Heart Rate Variability. Frontiers in Neuroscience. 13:1447. 2019
- Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication. Journal of the Canadian Association of Gastroenterology. 1:155-158. 2018
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. Trials. 19:606. 2018
- Getting fit for hip and knee replacement: a protocol for the Fit-Joints pilot randomized controlled trial of a multi-modal intervention in frail patients with osteoarthritis. Pilot and Feasibility Studies. 4:127. 2018
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. The BMJ. 363:k3750-k3750. 2018
- A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups. Gastroenterology Nursing. 41:427-435. 2018
- Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn’s disease. American Journal of Physiology - Gastrointestinal and Liver Physiology. 315:G420-G431. 2018
- Systematic review into obesity and weight gain within male prisons. Obesity Research and Clinical Practice. 12:327-335. 2018
- Clinical Practice Guidelines for the Assessment of Uninvestigated Esophageal Dysphagia. Journal of the Canadian Association of Gastroenterology. 1:5-19. 2018
- Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry. Frontiers in Physiology. 9:1248. 2018
- Communicating Gastrointestinal Symptoms: The Patient’s Challenge. Critical Reviews in Biomedical Engineering. 46:83-92. 2018
- Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 153:395-409.e3. 2017
- Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement”. Canadian Journal of Gastroenterology and Hepatology. 2017:1-1. 2017
- Changes in Home Parenteral Nutrition Practice Based on the Canadian Home Parenteral Nutrition Patient Registry. Journal of Parenteral and Enteral Nutrition. 41:830-836. 2017
- World Gastroenterology Organisation Global Guidelines. Journal of Clinical Gastroenterology. 51:467-478. 2017
- Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology. 152:497-514. 2017
- Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents. Canadian Journal of Gastroenterology and Hepatology. 2017:1-11. 2017
- Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist. Pharmacy Practice. 14:868-868. 2016
- Canadian Association of Gastroenterology: Strategic Plan 2016–2020. Canadian Journal of Gastroenterology and Hepatology. 2016:1-3. 2016
- Deep Learning in Gastrointestinal Endoscopy. Critical Reviews in Biomedical Engineering. 44:493-504. 2016
- Malnutrition Matters in Canadian Hospitalized Patients. Nutrition in Clinical Practice. 30:709-713. 2015
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 149:102-109.e6. 2015
- Management of reflux esophagitis: does the choice of proton pump inhibitor matter?. International Journal of Clinical Practice. 69:796-801. 2015
- Epidemiology and Risk Factors for Bloodstream Infections in a Home Parenteral Nutrition Program. Journal of Parenteral and Enteral Nutrition. 39:147-153. 2015
- Response to Atreja et al.. American Journal of Gastroenterology. 110:346-347. 2015
- WDHD May 29, 2015. Heartburn: A global perspective: Message from the Chair. South African Gastroenterology Review. 13:32. 2015
- Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis. Gastroenterology. 147:1255-1266.e21. 2014
- Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 109:811-819. 2014
- Adherence to Guidelines: A National Audit of the Management of Acute upper Gastrointestinal Bleeding. The REASON Registry. Canadian Journal of Gastroenterology and Hepatology. 28:495-501. 2014
- GERD and Obesity: Is the Autonomic Nervous System the Missing Link?. Critical Reviews in Biomedical Engineering. 42:17-24. 2014
- Quality Indicators for Colonoscopy: The Road Forward. Canadian Journal of Gastroenterology and Hepatology. 28:242-242. 2014
- Gamma-amino butyric acid (GABA) receptor agonists for gastroesophageal reflux disease (GERD). Cochrane Database of Systematic Reviews. 2013. 2013
- Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report.. Canadian Family Physician. 59:1055-e448. 2013
- What is the role of endoscopy and oesophageal biopsies in the management of GERD?. Best Practice and Research in Clinical Gastroenterology. 27:373-385. 2013
- Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease. Clinical Respiratory Journal. 2013. 2013
- The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care. Alimentary Pharmacology and Therapeutics. 37:730-737. 2013
- Novel Pharmaceutical Approaches to Reflux Disease. Gastroenterology Clinics of North America. 42:93-117. 2013
- Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:E156-E166. 2013
- Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes. Inflammatory Bowel Diseases. 19:332-341. 2013
- Patient-Identified Quality Indicators for Colonoscopy Services. Canadian Journal of Gastroenterology and Hepatology. 27:25-32. 2013
- Summary of Guidelines for Infection Prevention and Control for Flexible Gastrointestinal Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 27:347-350. 2013
- The 2012 Sage Wait Times Program: Survey of Access to Gastroenterology in Canada. Canadian Journal of Gastroenterology and Hepatology. 27:83-89. 2013
- Prevalence of Helicobacter pylori infection in children in the Bahamas.. West Indian Medical Journal. 61:698-702. 2012
- Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process. Gastroenterology. 143:336-346. 2012
- Canadian Home Parenteral Nutrition (HPN) Registry. Journal of Parenteral and Enteral Nutrition. 36:407-414. 2012
- The Canadian Home Total Parenteral Nutrition (HTPN) Registry. Journal of Parenteral and Enteral Nutrition. 36:415-420. 2012
- Improving serological test ordering patterns for the diagnosis of celiac disease through clinical laboratory audit of practice. Clinical Biochemistry. 45:455-459. 2012
- A Survey of the Practice of After-Hours and Emergency Endoscopy in Canada. Canadian Journal of Gastroenterology and Hepatology. 26:871-876. 2012
- Canadian Association of Gastroenterology Consensus Guidelines on Safety and Quality Indicators in Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 26:17-31. 2012
- Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement. Canadian Journal of Gastroenterology and Hepatology. 26:819-829. 2012
- Indicators of Safety Compromise in Gastrointestinal Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 26:71-78. 2012
- Predictors of a Variceal Source among Patients Presenting with Upper Gastrointestinal Bleeding. Canadian Journal of Gastroenterology and Hepatology. 26:187-192. 2012
- Report on the Expert Forum on using Information Technology to Facilitate Uptake and Impact of Colorectal Cancer Screening Guidelines. Canadian Journal of Gastroenterology and Hepatology. 26:902-904. 2012
- Safety of Esophagogastroduodenoscopy within 30 Days of Myocardial Infarction: A Retrospective Cohort Study from a Canadian Tertiary Centre. Canadian Journal of Gastroenterology and Hepatology. 26:151-154. 2012
- New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Thoracic Surgery Clinics. 21:557-574. 2011
- Barrett's esophagus: histology and immunohistology. Annals of the New York Academy of Sciences. 1232:76-92. 2011
- Barrett's esophagus: proton pump inhibitors and chemoprevention II. Annals of the New York Academy of Sciences. 1232:114-139. 2011
- A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surgical Endoscopy. 25:2547-2554. 2011
- Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation. Value in Health. 14:263-273. 2011
- A Literature Review of Quality in Lower Gastrointestinal Endoscopy from the Patient Perspective. Canadian Journal of Gastroenterology and Hepatology. 25:681-685. 2011
- Point-of-Care, Peer-Comparator Colonoscopy Practice Audit: The Canadian Association of Gastroenterology Quality Program – Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 25:13-20. 2011
- Testing for Gluten-Related Disorders in Clinical Practice: The Role of Serology in Managing the Spectrum of Gluten Sensitivity. Canadian Journal of Gastroenterology and Hepatology. 25:193-197. 2011
- Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. Muscle and Nerve. 42:853-855. 2010
- The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial. American Journal of Gastroenterology. 105:2341-2346. 2010
- New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America. 39:393-418. 2010
- Measuring Quality of Care in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage: Development of an Explicit Quality Indicator Set. American Journal of Gastroenterology. 105:1710-1718. 2010
- The pharmacodynamics and pharmacokinetics of S‐tenatoprazole‐Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects. Alimentary Pharmacology and Therapeutics. 31:648-657. 2010
- Latin American Consensus on Gastroesophageal Reflux Disease: An Update on Therapy. Gastroenterologia y Hepatologia. 33:135-147. 2010
- A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care. Canadian Journal of Gastroenterology and Hepatology. 24:489-498. 2010
- Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity. American Journal of Gastroenterology. 104:1587-1594. 2009
- Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study. Alimentary Pharmacology and Therapeutics. 29:1165-1171. 2009
- Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study. Alimentary Pharmacology and Therapeutics. 29:959-966. 2009
- Non-Variceal Upper GI Bleeding in Patients Already Hospitalized for Another Condition. American Journal of Gastroenterology. 104:330-339. 2009
- Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. Journal of Clinical Epidemiology. 62:102-110. 2009
- Response:. Gastrointestinal Endoscopy. 68:810-811. 2008
- Systematic review: persistence and severity in gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 28:841-853. 2008
- Should patients with Barrett's oesophagus be kept under surveillance? The case for. Best Practice and Research in Clinical Gastroenterology. 22:721-739. 2008
- Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z. Alimentary Pharmacology and Therapeutics. 28:187-199. 2008
- EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointestinal Endoscopy. 67:235-244. 2008
- A Critical Assessment of the Current Status of Non-Erosive Reflux Disease. Digestion. 78:46-54. 2008
- Access to Specialist Gastroenterology Care in Canada: Comparison of Wait Times and Consensus Targets. Canadian Journal of Gastroenterology and Hepatology. 22:161-167. 2008
- Access to Specialist Gastroenterology Care in Canada: The Practice Audit in Gastroenterology (PAGE) Wait Times Program. Canadian Journal of Gastroenterology and Hepatology. 22:155-160. 2008
- Canadian Credentialing Guidelines for Colonoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:17-22. 2008
- Canadian Credentialing Guidelines for Endoscopic Retrograde Cholangiopancreatography. Canadian Journal of Gastroenterology and Hepatology. 22:547-551. 2008
- Canadian Credentialing Guidelines for Esophagogastroduodenoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:349-354. 2008
- Canadian Credentialing Guidelines for Flexible Sigmoidoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:115-119. 2008
- Low Prevalence ofHelicobacter PyloriInfection in Canadian Children: A Cross-Sectional Analysis. Canadian Journal of Gastroenterology and Hepatology. 22:485-489. 2008
- Die Montreal-Definition und -Klassifikation der gastroösophagealen Refluxkrankheit: Ein globales evidenzbasiertes Konsensus-Papier. Zeitschrift für Gastroenterologie. 45:1125-1140. 2007
- Evaluation of densitometric bone–muscle relationships in Crohn's disease. Bone. 40:1610-1614. 2007
- Juvenile onset of Crohn's disease: A risk factor for reduced lumbar bone mass in premenopausal women. Bone. 40:1290-1293. 2007
- Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire. Alimentary Pharmacology and Therapeutics. 25:1087-1097. 2007
- GERD Evaluation. Journal of Clinical Gastroenterology. 41:237-241. 2007
- Simple Clinical Predictors May Obviate Urgent Endoscopy in Selected Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding. JAMA Internal Medicine. 167:265-265. 2007
- Canadian Credentialing Guidelines for Endoscopic Privileges: An Overview. Canadian Journal of Gastroenterology and Hepatology. 21:797-801. 2007
- Cancer Care Ontario Colonoscopy Standards: Standards and Evidentiary Base. Canadian Journal of Gastroenterology and Hepatology. 21:5D-24D. 2007
- Clinical Onset of Celiac Disease after an Episode ofCampylobacter jejuniEnteritis. Canadian Journal of Gastroenterology and Hepatology. 21:453-455. 2007
- Determination of ReQuest<sup>TM</sup>-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 75:55-61. 2007
- Endoscopy and Quality Assurance – It is Here!. Canadian Journal of Gastroenterology and Hepatology. 21:255-256. 2007
- Evaluation of GERD Symptoms during Therapy. Digestion. 75:41-47. 2007
- Evaluation of GERD Symptoms during Therapy. Digestion. 75:32-40. 2007
- Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients. Canadian Journal of Gastroenterology and Hepatology. 21:637-642. 2007
- International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease. Digestion. 75:48-54. 2007
- Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 25:185-196. 2007
- Photodynamic Therapy for Barrett’s Esophagus with High-Grade Dysplasia: A Cost-Effectiveness Analysis. Canadian Journal of Gastroenterology and Hepatology. 21:217-222. 2007
- Systematic Review: Do We Need a New Gastro-Oesophageal Reflux Disease Questionnaire?. Digestion. 75:3-16. 2007
- The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art. Digestion. 75:17-24. 2007
- The Effect of Sham Feeding on Neurocardiac Regulation in Healthy Human Volunteers. Canadian Journal of Gastroenterology and Hepatology. 21:721-726. 2007
- The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD). PharmacoEconomics (Auckland). 25:385-396. 2007
- A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up. Surgical Innovation. 13:238-249. 2006
- C-13 urea breath test for Helicobacter pylori: Determination of the optimal cut-off point in a Canadian community population. Canadian Journal of Gastroenterology and Hepatology. 20:770-774. 2006
- C-13 urea breath test for Helicobacter pylori: Evaluation of 10-minute breath collection. Canadian Journal of Gastroenterology and Hepatology. 20:775-778. 2006
- The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria. Gastroenterology. 131:1392-1399. 2006
- Efficacy of Anal Fistula Plug in Closure of Crohn's Anorectal Fistulas. Diseases of the Colon and Rectum. 49:1569-1573. 2006
- Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial. American Journal of Gastroenterology. 101:2096-2106. 2006
- Predictors of treatment response in patients with non‐erosive reflux disease. Alimentary Pharmacology and Therapeutics. 24:371-376. 2006
- An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease. European Journal of Gastroenterology and Hepatology. 18:349-368. 2006
- Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study. Current Medical Research and Opinion. 22:657-662. 2006
- The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Alimentary Pharmacology and Therapeutics. 23:595-599. 2006
- Errata. Alimentary Pharmacology and Therapeutics. 23:449-449. 2006
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.(vol 22, pg 803, 2005). Alimentary Pharmacology and Therapeutics. 23:449-449. 2006
- Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Alimentary Pharmacology and Therapeutics. 23:521-529. 2006
- Validation of a symptom diary for patients with gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 23:531-541. 2006
- 13C Urea Breath Test for Helicobacter pylori: Determination of the Optimal Cut-Off Point in a Canadian Community Population. Canadian Journal of Gastroenterology. 20:770-774. 2006
- 13C Urea Breath Test forHelicobacter pylori: Evaluation of 10-minute Breath Collection. Canadian Journal of Gastroenterology. 20:775-778. 2006
- Practice Audit in Gastroenterology (Page) Program: A Novel Approach to Continuing Professional Development. Canadian Journal of Gastroenterology and Hepatology. 20:405-410. 2006
- Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. World Journal of Gastroenterology. 12:7779-7779. 2006
- Gastroesophageal reflux disease. Current Opinion in Pharmacology. 5:589-595. 2005
- The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterology. 5:23. 2005
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1. Alimentary Pharmacology and Therapeutics. 22:803-811. 2005
- Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers. American Journal of Gastroenterology. 100:1949-1956. 2005
- A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study. American Journal of Gastroenterology. 100:1477-1488. 2005
- Economic Analysis of Home vs Hospital‐Based Parenteral Nutrition in Ontario, Canada. Journal of Parenteral and Enteral Nutrition. 29:266-269. 2005
- Noninvasive Verification of Nasogastric Tube Placement Using a Magnet‐Tracking System: A Pilot Study in Healthy Subjects. Journal of Parenteral and Enteral Nutrition. 29:305-310. 2005
- Heartburn‐dominant, uninvestigated dyspepsia: a comparison of ‘PPI‐start’ and ‘H2‐RA‐start’ management strategies in primary care – the CADET‐HR Study. Alimentary Pharmacology and Therapeutics. 21:1189-1202. 2005
- A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Alimentary Pharmacology and Therapeutics. 21:739-746. 2005
- A Sampling of Canadian Practice in Managing Nonvariceal Upper Gastrointestinal Bleeding before Recent Guideline Publication: Is there Room for Improvement?. Canadian Journal of Gastroenterology and Hepatology. 19:487-495. 2005
- Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 71:145-151. 2005
- Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool. Canadian Journal of Gastroenterology and Hepatology. 19:285-303. 2005
- Intravenous proton pump inhibitor therapy: a rationale for use.. Reviews in Gastroenterological Disorders. 5 Suppl 2:S18-S30. 2005
- Reflux Questionnaire (ReQuest™). Digestion. 71:173-173. 2005
- Reply. Digestion. 71:174-175. 2005
- The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole.. Health and Quality of Life Outcomes. 3:4-4. 2005
- Validation of a Short Questionnaire in English and French for Use in Patients with Persistent Upper Gastrointestinal Symptoms Despite Proton Pump Inhibitor Therapy: The Pass (Proton Pump Inhibitor Acid Suppression Symptom) Test. Canadian Journal of Gastroenterology and Hepatology. 19:350-358. 2005
- A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease. Medical Care. 42:1132-1142. 2004
- Do physicians correctly assess patient symptom severity in gastro‐oesophageal reflux disease?. Alimentary Pharmacology and Therapeutics. 20:1161-1169. 2004
- Does Helicobacter pylori infection and its eradication have any effect on heartburn and gastroesophageal reflux?. Nature Reviews Gastroenterology and Hepatology. 1:16-17. 2004
- International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 20:891-898. 2004
- Review article: gastric pH — the most relevant predictor of benefit in reflux disease?. Alimentary Pharmacology and Therapeutics. 20:19-26. 2004
- Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia. Alimentary Pharmacology and Therapeutics. 20:40-47. 2004
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. (vol 17, pg 1481, 2003). Alimentary Pharmacology and Therapeutics. 20:702-702. 2004
- Corrigenda. Alimentary Pharmacology and Therapeutics. 20:702-702. 2004
- The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting. American Journal of Gastroenterology. 99:1238-1246. 2004
- Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 53:iv1-iv24. 2004
- Do we need a new gastro‐oesophageal reflux disease questionnaire?. Alimentary Pharmacology and Therapeutics. 19:463-479. 2004
-
Economic evaluation of
Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial ofH. pylori ‐positive primary care patients with uninvestigated dyspepsia. Alimentary Pharmacology and Therapeutics. 19:349-358. 2004 - Peripheral intravenous infusion of potassium chloride: Effect of solution composition on infusion-site pain. Canadian Journal of Hospital Pharmacy. 57:27-31. 2004
- A Canadian Clinical Practice Algorithm for the Management of Patients with Non-Variceal Upper Gastrointestinal Bleeding. Canadian Journal of Gastroenterology and Hepatology. 18:605-609. 2004
- A comparison of narrative and table formats for presenting hypothetical health states to patients with gastrointestinal or pulmonary disease. Medical decision making. 24:53-60. 2004
- Canadian Helicobacter Study Group Consensus Conference: Update on the Management ofHelicobacter pylori- An Evidence-Based Evaluation of Six Topics Relevant to Clinical Outcomes in Patients Evaluated forH pyloriInfection. Canadian Journal of Gastroenterology and Hepatology. 18:547-554. 2004
- Evaluation of GERD Symptoms during Therapy. Part I. Digestion. 69:229-237. 2004
- Evaluation of GERD Symptoms during Therapy. Part II. Digestion. 69:238-244. 2004
- Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body Myositis. Canadian Journal of Gastroenterology and Hepatology. 18:397-399. 2004
- The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art. Digestion. 70:71-78. 2004
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 18:705-711. 2003
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 18:705-711. 2003
- Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn. Journal of Clinical Gastroenterology. 37:132-138. 2003
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Alimentary Pharmacology and Therapeutics. 17:1481-1491. 2003
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study. Alimentary Pharmacology and Therapeutics. 17:1481-1491. 2003
- GERD 2003 – A Consensus on the Way Ahead. Digestion. 67:111-117. 2003
- Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology. 17:307-312. 2003
- Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. European Journal of Gastroenterology and Hepatology. 14:857-863. 2002
- Early relief of upper gastrointestinal dyspeptic symptoms: A survey of empirical therapy with pantoprazole in Canadian clinical practice. Canadian Journal of Gastroenterology and Hepatology. 16:443-454. 2002
- Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice. Canadian Journal of Gastroenterology and Hepatology. 16:439-450. 2002
- Effect of Omeprazole on Regional and Temporal Variations in Intragastric Acidity. Digestion. 65:2-10. 2002
- Motion – All Patients with GERD Should Be Offered Once in a Lifetime Endoscopy: Arguments for the Motion. Canadian Journal of Gastroenterology and Hepatology. 16:549-551. 2002
- Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.. American Journal of Gastroenterology. 96:2849-2857. 2001
- Re: Ammonia cannot explain the effect of H-pylori on omeprazole-induced acid suppression - Response to Dr. McColl et al.. American Journal of Gastroenterology. 96:602-604. 2001
- Gastric acidity and preneoplastic/neoplastic changes of the stomach.. European Journal of Gastroenterology and Hepatology. 12:1353-1354. 2000
- Reply to: Gastric acidity and preneoplastic/neoplastic changes of the stomach. European Journal of Gastroenterology and Hepatology. 12:1354-1354. 2000
- Update from the Canadian Dyspepsia Working Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:696. 2000
- Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease. The Lancet. 356:610-612. 2000
- An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:S3-S23. 2000
- An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:S3-23. 2000
- The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects. Alimentary Pharmacology and Therapeutics. 14:535-541. 2000
- The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. American Journal of Gastroenterology. 95:947-955. 2000
- The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. European Journal of Gastroenterology and Hepatology. 12:165-173. 2000
- Test-and-Treat Strategies forHelicobacter pyloriin Uninvestigated Dyspepsia: A Canadian Economic Anaylsis. Canadian Journal of Gastroenterology and Hepatology. 14:379-388. 2000
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 45:172-180. 1999
- Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 161:154-160. 1999
- Endoscopic evaluation of gastro-esophageal reflux disease.. Yale Journal of Biology and Medicine. 72:93-100. 1999
- Management of Nonsteroidal Anti‐Inflammatory Drug‐Induced Gastroduodenal Disease by Acid Suppression. Canadian Journal of Gastroenterology and Hepatology. 13:135-142. 1999
- High Concentrations of Ammonia, But Not Volatile Amines, in Gastric Juice of Subjects with Helicobacter pylori Infection. Helicobacter. 3:97-102. 1998
- Letters to the Editors. Alimentary Pharmacology and Therapeutics. 12:395-396. 1998
- Omeprazole for Refractory Gastroesophageal Reflux Disease during Pregnancy and Lactation. Canadian Journal of Gastroenterology and Hepatology. 12:225-227. 1998
- The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts. Canadian Journal of Gastroenterology and Hepatology. 12:551-556. 1998
- Reflux esophagitis and H. pylori.. Gastroenterology. 113:2020-2021. 1997
- Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:51B-54B. 1997
- The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:7B-20B. 1997
- Omeprazole--a new formulation.. Canadian Journal of Gastroenterology and Hepatology. 11:655-656. 1997
- Helicobacter pylori infection and omeprazole efficacy. Gastroenterology. 111:1401-1403. 1996
- Effects of misoprostol on healing and prevention of biopsy‐induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Alimentary Pharmacology and Therapeutics. 10:563-569. 1996
- The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology. 111:85-92. 1996
- Helicobacter pyloriInfection and Dyspepsia. Scandinavian Journal of Gastroenterology. 31:38-47. 1996
- Erratum: Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Alimentary Pharmacology and Therapeutics. 10:833. 1996
- Helicobacter pylori in the pathogenesis of disease. American Journal of Roentgenology. 166:209-210. 1996
- Infection with Helicobacter pylori.. American Journal of Roentgenology. 166:209-210. 1996
- Intragastric pH during Treatment with Omeprazole: Role ofHelicobacter pyloriandH. pylori-Associated Gastritis. Scandinavian Journal of Gastroenterology. 31:1151-1156. 1996
- Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.. Gut. 37:743-748. 1995
- Endoscopic Features of Helicobacter pylori-Related Gastritis. Endoscopy. 27:593-596. 1995
- Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.. Zeitschrift für Gastroenterologie. 33:509-512. 1995
- FUNCTIONAL DYSPEPSIA - APPROACH FOR HELICOBACTER THERAPY. Leber, Magen, Darm. 25:112-&. 1995
- [Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].. Leber, Magen, Darm. 25:112-120. 1995
- Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.. Gut. 36:539-543. 1995
- The Origin of Nocturnal Intragastric pH Rises in Healthy Subjects. Scandinavian Journal of Gastroenterology. 30:935-943. 1995
- Gastroesophageal reflux disease, pH monitoring, and treatment. Current Opinion in Gastroenterology. 10:426-438. 1994
- RUDER—A prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. Digestive Diseases and Sciences. 39:1425-1433. 1994
- Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.. Gut. 35:455-460. 1994
- Origins of motility patterns in isolated arterially perfused rat intestine. Gastroenterology. 106:649-657. 1994
- Gastric mucosal toxicity of duodenal juice constituents in the rat. Digestive Diseases and Sciences. 39:327-339. 1994
- Effects of Omeprazole and Lansoprazole on 24-Hour Intragastric pH in Helicobacter pylori-Positive Volunteers. Scandinavian Journal of Gastroenterology. 29:1065-1069. 1994
- Reflux Disease and Barrett's Oesophagus. Endoscopy. 26:9-19. 1994
- Nocturnal oesophageal motor activity is dependent on sleep stage.. Gut. 34:1653-1659. 1993
- Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group.. Gut. 34:1319-1326. 1993
- Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.. Gut. 34:1025-1031. 1993
- Does long-term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease?. European Journal of Gastroenterology and Hepatology. 5:311-318. 1993
- CONTINUOUS MEASUREMENT OF RAT GASTRIC BLOOD-FLOW USING DOPPLER FLOWMETER. American Journal of Physiology. 264:G686-G692. 1993
- Continuous measurement of rat gastric blood flow using Doppler flowmeter. American Journal of Physiology. 264:G686-G692. 1993
- Diagnosis and assessment of gastro-oesophageal reflux disease. Gullet. 3:31-41. 1993
- RELAPSE PROPHYLAXIS OF ULCER DISEASE - INDICATION AND CHOICE OF PROCEDURE. Therapeutische Umschau. Revue therapeutique. 49:761-775. 1992
- [Prevention of recurrence of ulcer disease: indications and choice of procedure].. Therapeutische Umschau. Revue therapeutique. 49:761-775. 1992
- Gastroesophageal reflux disease, pH monitoring, and treatment. Current Opinion in Gastroenterology. 8:562-572. 1992
- ESOPHAGEAL PH-METRY - SHOULD MEALS BE STANDARDIZED. Scandinavian Journal of Gastroenterology. 27:350-354. 1992
- The effect of continuous enteral nutrition on gastric acidity in humans. Gastroenterology. 102:1506-1515. 1992
- Maintenance therapy: Is there still a place for antireflux surgery?. World Journal of Surgery. 16:300-307. 1992
- Gastroenterology: Non-peptic diseases. Medecine et Hygiene. 50:216-232. 1992
- Gastroenterology: Peptic diseases. Medecine et Hygiene. 50:206-214. 1992
- Hepatology. Medecine et Hygiene. 50:233-245. 1992
- Influence of Stress on the Healing and Relapse of Duodenal Ulcers: A Prospective, Multicenter Trial of 2109 Patients with Recurrent Duodenal Ulceration Treated with Ranitidine. Scandinavian Journal of Gastroenterology. 27:917-923. 1992
- Liver and bile duct diseases. Progress report 1991. Therapiewoche Schweiz. 8:443-463. 1992
- Non-peptic lesions. Advancements in 1991. Therapiewoche Schweiz. 8:371-394. 1992
- Oesophageal pH-Metry: Should Meals Be Standardized?. Scandinavian Journal of Gastroenterology. 27:350-354. 1992
- Peptic lesions. Therapiewoche Schweiz. 8:199-219. 1992
- Reflux Disease and Barrett's Oesophagus. Endoscopy. 24:9-17. 1992
- Computer-assisted ambulatory long-term manometry of tubular esophagus. Digestive Diseases and Sciences. 36:90S-97S. 1991
- Gastroesophageal reflux disease and pH monitoring. Current Opinion in Gastroenterology. 7:545-556. 1991
- Reproducibility of long-term ambulatory esophageal combined pH/manometry. Gastroenterology. 100:1630-1637. 1991
- Diclofenac delays healing of gastroduodenal mucosal lesions. Digestive Diseases and Sciences. 36:594-600. 1991
- FAMOTIDINE SHOULD BE TAKEN WITH SUPPER - THE EFFECT OF DRUG MEAL INTERACTIONS ON GASTRIC-ACIDITY AND PLASMA FAMOTIDINE LEVELS. European Journal of Gastroenterology and Hepatology. 3:405-412. 1991
- RUDER: interim evaluation of a 2-year, multicentre study of risk factors for duodenal ulcer relapse.. Zeitschrift fur Gastroenterologie. Verhandlungsband. 26:171-172. 1991
- Advancements in the treatment of peptic lesions during 1990. Therapiewoche. 41:929-952. 1991
- Gastroenterolgy. 1. Peptic lesions. Medecine et Hygiene. 49:222-232. 1991
- Gastroenterology. 2. Non-peptic lesions. Medecine et Hygiene. 49:233-245. 1991
- Hepatology. Medecine et Hygiene. 49:246-257. 1991
- Liver and biliary tract disease: Advances in 1990. Therapiewoche Schweiz. 7:390-408. 1991
- Liver and biliary tract diseases: Advances in 1990. Therapiewoche. 41:1339-1364. 1991
- New perspectives in peptic esophagitis. Medecine et Hygiene. 49:210-221. 1991
- Non-peptic lesions: Progress report 1990. Therapiewoche Schweiz. 7:319-335. 1991
- Peptic lesions: progress report 1990. Therapiewoche Schweiz. 7:225-242. 1991
- Therapeutic advancements during 1990: Non-peptic lesions. Therapiewoche. 41:1133-1158. 1991
- Endoscopic assessment of oesophagitis. Gullet. 1:63-67. 1990
- 24-HOUR PATTERN OF ESOPHAGEAL MOTILITY IN ASYMPTOMATIC VOLUNTEERS. Digestive Diseases and Sciences. 35:1190-1197. 1990
- Twenty-four-hour pattern of esophageal motility in asymptomatic volunteers. Digestive Diseases and Sciences. 35:1190-1197. 1990
- Ambulatory Esophageal Manometry: Comparison of Expert and Computer‐Aided Analyses. Neurogastroenterology and Motility. 2:216-223. 1990
- CONTINUOUS LONG-TERM GASTRIC PH-METRY - FURTHER SUGGESTIONS FOR OPTIMIZING DATA-ANALYSIS - REPLY. European Journal of Gastroenterology and Hepatology. 2:320-323. 1990
- Fate of antacid gel in the stomach. Digestive Diseases and Sciences. 35:553-558. 1990
- Ambulatory esophageal manometry: Comparison of expert and computer-aided analyses. Neurogastroenterology and Motility. 2:216-223. 1990
- Digestive system function disorders: Physiopathologic approach. 1. Introduction, chest pain, and dyspepsia. Medecine et Hygiene. 48:225-232. 1990
- Digestive system function disorders: Physiopathologic approach. 2. Irritable bowel and constipation. Medecine et Hygiene. 48:233-239. 1990
- Gastroenterology. 1. Peptic disorders. Medecine et Hygiene. 48:240-248. 1990
- Gastroenterology. 2. Non-peptic disorders. Medecine et Hygiene. 48:249-260. 1990
- Non-peptic lesions: Advancements during 1989. Therapiewoche Schweiz. 6:361-383. 1990
- Peptic lesions: Progress during 1989. Therapiewoche Schweiz. 6:167-186. 1990
- Reproducibility of Ambulatory Gastric pH Recordings in the Corpus and Antrum: Effect of Food, Time, and Electrode Position. Scandinavian Journal of Gastroenterology. 25:1076-1083. 1990
- The short-term treatment of peptic lesions. Therapiewoche. 40:1107-1129. 1990
- Review twenty-four-hour intragastric pH-metry studies: Easy to do but difficult to analyse. European Journal of Gastroenterology and Hepatology. 1:167-174. 1989
- Is the ex vivo rat gastric chamber model suitable for studying the gastrotoxicity of refluxed duodenal contents? Initial results using deoxycholic acid. Clinica Chimica Acta. 178:313-325. 1988
- Sequential endoscopy and biopsy of intact rat stomach. Digestive Diseases and Sciences. 33:321-323. 1988